18 11, 2024

Qkine and inscreenex collaborate to test cell models for drug discovery, disease modeling, and personalized medicine

2024-11-19T19:09:50+00:00November 18th, 2024|News, Press Release|

Through its pioneering cell-type-specific immortalization technology, inscreenex empowers scientists to overcome the limitations of primary cell cultures, offering long-lasting and functional cell lines that are ideal for applications in drug discovery, disease modeling, and personalized medicine. Collaboration with Qkine merges their expertise with that of Qkine in complex protein manufacturing and engineering to allow testing and validation of cell responses in disease modelling.

15 11, 2024

CARMA panel discussion: How can we best transform academic innovation into scalable industrial processes? Part 3

2024-11-15T11:48:50+00:00November 15th, 2024|Blog, cellular agriculture|

This blog focuses academic-industrial relationships, what academic laboratories can learn from industrial experts. Read the other blogs for more insights.

15 11, 2024

CARMA panel discussion: How can we best transform academic innovation into scalable industrial processes? Part 2

2024-11-15T11:50:31+00:00November 15th, 2024|Blog, cellular agriculture|

This blog focuses Importance of cell and growth factor selection and how this can affect the future regulatory approval and future commercialization of academic research. Read the other blogs for more insights.

15 11, 2024

CARMA panel discussion: How can we best transform academic innovation into scalable industrial processes? Part 1

2024-11-15T12:00:41+00:00November 15th, 2024|Blog, cellular agriculture|

The panel discussion offered perspectives from companies working to bring cultivated meat, fish, fat and dairy to consumers. The aim was to inspire early career researchers and demystify research in this industry to highlight and encourage transitions in both directions between academia and industry. This blog focuses on the current regulatory frameworks and how the future of regulation may impact both industry and the future commercialization of academic research. Read the follow up blogs for more insights.

15 11, 2024

Pep Talk November 2024

2024-11-16T11:11:23+00:00November 15th, 2024|Awards, News, newsletter, Resources|

In this edition, we are excited to announce two new distributor agreements, our products will now be available in Türkiye and SLS will be making our products more accessible in the UK and Ireland. Our latest offer, buy 2 get 1 free and other news, the launch of our high quality food grade range.

7 11, 2024

Qkine announces a new sales distribution agreement in Türkiye with distributor Pitagen

2024-11-11T15:59:58+00:00November 7th, 2024|News, Press Release|

‍Qkine, a leading manufacturer of high purity bioactive proteins, is pleased to announce its new sales distribution agreement with leading Turkish cell biology and stem cell reagent supplier Pitagen.

7 11, 2024

Qkine announces a new UK & Ireland sales distribution agreement with SLS

2024-11-11T16:03:26+00:00November 7th, 2024|News, Press Release|

Qkine is pleased to announce a new UK & Ireland sales distribution agreement with SLS, the largest independent supplier of laboratory equipment, chemicals, and consumables in the UK.

25 10, 2024

Qkine featured in the Nikkei Biotechnology & Business magazine

2024-10-25T11:59:43+00:00October 25th, 2024|Blog, cellular agriculture|

Qkine are delighted that our eel FGF-2 proteins have elicited interest in Japan, recently the Nikkei Biotechnology & Business magazine have published an article focussing on the 145 and 154 amino acid versions of eel FGF-2, and the contribution Qkine species specific growth factors can have on the cultured seafood industry.

24 10, 2024

Qkine strengthens its support for the cellular agriculture through provision of high quality food grade growth factors

2024-10-24T21:40:13+00:00October 24th, 2024|cellular agriculture, News|

Qkine announces the provision of a new range of high quality food grade growth factors as part of our commitment to driving innovation in the functional recombinant growth factor supply chain for emerging sectors including cultivated meat, fish, fat and dairy.

Go to Top